Stroke Diagnostics and Therapeutics Market Size, Share, Growth Report 2032

Stroke Diagnostics and Therapeutics Market Size

The global Stroke Diagnostics and Therapeutics Market accrued earnings worth approximately 28.11 (USD Billion) in 2021 and is predicted to gain revenue of about 50.12 (USD Billion) by 2028, is set to record a CAGR of nearly 7% over the period from 2022 to 2028. The study provides an assessment and analysis of the Stroke Diagnostics and Therapeutics Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Billion).

Request Free Sample

Stroke Diagnostics and Therapeutics Market: Overview

Attack on brain is referred as stroke and it is caused due to reduction of blood supply to brain. This has resulted in brain not getting appropriate proportion of oxygen causing brain cells to die. Increase in people prone to stokes will steer expansion of stroke diagnostics and therapeutics industry. There are three kinds of stroke including ischemic, transient ischemic attacks, and hemorrhagic. In first kind, i.e. ischemic stroke, flow of blood to brain is reduced in arteries owing to narrowed & blocked blood vessels. Hemorrhagic stroke is due to brain arteries leaking or bursting. However, transient ischemic attacks interrupt temporary blood flow to brain for shorter period. Diagnosis of stroke includes MRI scanning, ultrasound, CT scan, echocardiogram, and cerebral angiogram. The treatment or therapeutics part include intake of aspirin, anticoagulants, and antiplatelets.

COVID-19 Impact Analysis of Stroke Diagnostics and Therapeutics Market

Apart from impacting human health, treating of patients having COVID-19 has also financial impact. Changing customer preferences towards healthcare solutions during COVID-19 pandemic has majorly impacted stroke diagnostics and therapeutics market. While direct impact of COVID-19 has been substantial, additional layers of indirect impact of pandemic possess potential for dwarfing immediate effects. This indirect effect of COVID-19 has resulted in increment of healthcare costs worth billions of dollars. For the record, COVID-19 had incurred costs about nearly USD 126 billion to USD 200 billion on U.S. healthcare systems in 2019-2020.  

Request Free Sample

Stroke Diagnostics and Therapeutics Market: Dynamics

• Drivers: Rise in health awareness and surge in cases of diabetes will boost expansion of stroke diagnostics and therapeutics market. A massive increment in tobacco consumers and a huge rise in aging populace prone to stokes will steer market growth.
• Restraints: Huge diagnosis & treatment costs and improper compensation policies can hinder growth of stroke diagnostics and therapeutics market.
• Opportunities: Technological breakthroughs in diagnosis & therapeutics sector have resulted in effective treatment of stroke, thereby creating new growth avenues for stroke diagnostics and therapeutics market.
• Challenges: Lockdown has resulted in shutdown of units manufacturing diagnostic equipment, thereby impacting import & export of this equipment across globe. This has posed a big challenge to growth of stroke diagnostics and therapeutics market.

Stroke Diagnostics and Therapeutics Market: Segmentation

Based on segment, stroke diagnostics and therapeutics market is segregated into diagnostics and therapeutics. Application Wise, the market is divided into ischemic stroke and hemorrhage stroke.

Diagnostics Segment To Contribute Majorly Towards Market Size Over 2022-2028

Segmental dominance over next six years can be attributed to product innovation in stroke management equipment along with rise in cases of chronic disorders such as diabetes and heart disorders.

Ischemic Stroke Segment To Dominate Application Landscape By 2028

Surge in health consciousness among global population and rise in diabetics as well as tobacco consumers will drive segmental growth. Inflation in geriatric population susceptible to suffer form chronic disorders will drive market trends.

Report Scope:

Stroke Diagnostics and Therapeutics Market: Regional Insights

North America To Account Majorly Towards Regional Market Size By 2028

Growth of regional market over forecast timespan is subject to rise in frequency of chronic disorders such as diabetes in countries such as the U.S. Apart from this, massive use of stroke diagnostic devices and easy access to upgraded healthcare amenities in region will steer regional market expansion. Presence of qualified healthcare service providers in sub-continent will embellish expansion of stroke diagnostics and therapeutics market in North America.

In addition to this, Asia Pacific Market is predicted to register highest CAGR in next six years. The regional market surge can be attributed to availability of improved healthcare facilities, increase in number of ambulatory surgical centers, rise in number of hospitals equipped with new equipment, and new medical reforms. Breakthroughs in stroke management sector will accentuate regional market size. Countries such as Japan and China are likely to be major regional revenue contributors.

Key Industry Participants

Major players have dominated growth of stroke diagnostics and therapeutics market and will continue to do so even in foreseeable future. We have profiled them in our report and they are Siemens AG, Abbott Laboratories, Genentech, Inc., Stryker Corporation, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, and Merck & Co., Inc.

The global stroke diagnostics and therapeutics market is segmented as follows:

By Type

• Diagnostics
• Therapeutics

By Application

• Ischemic Stroke
• Hemorrhagic Stroke

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa